Group 1 - The core viewpoint of the news is that Aojing Medical's stock performance and financing activities indicate a low level of investor confidence, with a net financing buy of -58.05 million yuan on August 26 [1] - As of August 26, Aojing Medical's total financing and securities balance is 128 million yuan, which is 4.52% of its market capitalization, indicating a low financing level compared to the past year [1] - The company has not engaged in any short selling activities on August 26, with a short selling balance of 0, suggesting a lack of bearish sentiment among investors [1] Group 2 - As of March 31, Aojing Medical had 7,905 shareholders, a decrease of 2.85% from the previous period, while the average number of circulating shares per shareholder increased by 2.93% to 17,147 shares [2] - For the first quarter of 2025, Aojing Medical reported a revenue of 42.46 million yuan, a year-on-year decrease of 10.35%, and a net profit attributable to shareholders of 1.04 million yuan, down 84.99% year-on-year [2] - The company has distributed a total of 58.67 million yuan in dividends since its A-share listing, with 22.40 million yuan distributed over the past three years [3]
奥精医疗8月26日获融资买入828.32万元,融资余额1.28亿元